-
公开(公告)号:JPH10168062A
公开(公告)日:1998-06-23
申请号:JP33414897
申请日:1997-12-04
Applicant: HOECHST AG
Inventor: WEIDMANN KLAUS DR , BARINGHAUS KARL-HEINZ DR , TSCHANK GEORG DR , BICKEL MARTIN DR
IPC: C07D213/64 , A61K31/44 , A61P9/10 , A61P11/00 , A61P43/00 , C07D213/69 , C07D213/81
Abstract: PROBLEM TO BE SOLVED: To obtain the subject compound having inhibiting activity against prolylhydroxylase, capable of exhibiting biosynthesis suppressing effect for collagen and useful as a medicine for curing of fibrous disease. SOLUTION: This compound is expressed by formula I [R to R are each H; A is CH2 ; B is CO2 G G is an organic group making the compound the formula I to a prodrug containing a bioactive salt excepting 3-hydroxypyridine-2- carboxylic acid (glycyl) ethyl esteramide}] and 3-hydroxypyridine-2-carboxylic acid N-[ (1-dodecyloxy)carbonykyl}methyl]amide is exemplified. The compound of the formula I is obtained by, e.g. reacting a pyridine-2-carboxylic acid of formula II (R is H) with an amino ester of the formula H2 N-A-CO2 G or its salt. The compound can be used for fibrous disease, athereosclerosis, etc.
-
2.
公开(公告)号:CY2120B1
公开(公告)日:2002-04-26
申请号:CY9800039
申请日:1998-09-29
Applicant: HOECHST AG
Inventor: WEIDMANN KLAUS DR , BARINGHAUS KARL-HEINZ DR , TSCHANK GEORG DR , BICKEL MARTIN DR
IPC: C07D237/24 , A61K31/44 , A61K31/4412 , A61K31/4418 , A61K31/47 , A61K31/472 , A61K31/495 , A61K31/50 , A61P1/00 , A61P3/00 , A61P9/10 , A61P43/00 , C07D213/81 , C07D213/82 , C07D213/83 , C07D213/89 , C07D215/48 , C07D217/26 , C07D237/10 , C07D409/12 , C07K5/078
Abstract: The invention relates to compounds of the formula I a process for their preparation, and their use as medicaments. In particular, the compounds are employed for the inhibition of collagen biosynthesis, as inhibitors of proline hydroxylase and as fibrosuppressants.
-
公开(公告)号:CZ289356B6
公开(公告)日:2002-01-16
申请号:CZ268394
申请日:1994-11-01
Applicant: HOECHST AG
Inventor: WEIDMANN KLAUS DR , BARINGHAUS KARL-HEINZ DR , TSCHANK GEORG DR , BICKEL MARTIN DR
IPC: C07D237/24 , A61K31/44 , A61K31/4412 , A61K31/4418 , A61K31/47 , A61K31/472 , A61K31/495 , A61K31/50 , A61P1/00 , A61P3/00 , A61P9/10 , A61P43/00 , C07D213/81 , C07D213/82 , C07D213/83 , C07D213/89 , C07D215/48 , C07D217/26 , C07D237/10 , C07D409/12 , C07K5/078
Abstract: The present invention relates to heterocyclic carboxylic acid substituted amides of the general formula I, in which Q represents oxygen, sulfur or NH, m represents 0 or 1, Re1 represents for example an alkoxy group, Re2 represents for example a carboxy group, Re3 represents for example hydrogen, Re4 represents for example an alkyl group and A represents an optionally substituted methylene group. These compounds are particularly prepared by reacting pyridine-2-carboxylic acid of the general formula II with an amino ester of the general formula Hi2N-A-COORe24, whereupon a corresponding acid is extracted by saponification from the obtained compound. Said acid can be further transferred to an N-oxide or a salt. The above-indicated substituted amide are particularly used for inhibition of collagen biosynthesis, further as inhibitors of prolylhydroxylase and as fibrosuppressives.
-
公开(公告)号:ES2154266T3
公开(公告)日:2001-04-01
申请号:ES93104658
申请日:1993-03-22
Applicant: HOECHST AG
Inventor: WEIDMANN KLAUS DR , BICKEL MARTIN DR , GUNZLER-PUKALL VOLKMAR DR
IPC: A61K31/4402 , A61K31/4412 , A61K31/4418 , A61K31/4425 , A61K31/4427 , A61K31/44 , A61P3/00 , A61P7/04 , C07D213/81 , C07D213/82 , C07D213/83 , C07D213/89 , C07D401/12 , C07D409/12
Abstract: The invention relates to sulphonamido- and sulphonamidocarbonyl-pyridine-2-carboxamides of the general formula I and their use as medicines, in particular against fibrotic disorders.
-
公开(公告)号:DK0562512T3
公开(公告)日:2001-03-19
申请号:DK93104658
申请日:1993-03-22
Applicant: HOECHST AG
Inventor: BICKEL MARTIN DR , GUENZLER-PUKALL VOLKMAR DR , WEIDMANN KLAUS DR
IPC: A61K31/4402 , A61K31/4412 , A61K31/4418 , A61K31/4425 , A61K31/4427 , A61K31/44 , A61P3/00 , A61P7/04 , C07D213/81 , C07D213/82 , C07D213/83 , C07D213/89 , C07D401/12 , C07D409/12
Abstract: The invention relates to sulphonamido- and sulphonamidocarbonyl-pyridine-2-carboxamides of the general formula I and their use as medicines, in particular against fibrotic disorders.
-
公开(公告)号:AT199250T
公开(公告)日:2001-03-15
申请号:AT93104658
申请日:1993-03-22
Applicant: HOECHST AG
Inventor: WEIDMANN KLAUS DR , BICKEL MARTIN DR , GUENZLER-PUKALL VOLKMAR DR
IPC: A61K31/44 , A61K31/4402 , A61K31/4412 , A61K31/4418 , A61K31/4425 , A61K31/4427 , A61P3/00 , A61P7/04 , C07D213/81 , C07D213/82 , C07D213/83 , C07D213/89 , C07D401/12 , C07D409/12
Abstract: The invention relates to sulphonamido- and sulphonamidocarbonyl-pyridine-2-carboxamides of the general formula I and their use as medicines, in particular against fibrotic disorders.
-
公开(公告)号:ES2146676T3
公开(公告)日:2000-08-16
申请号:ES95103582
申请日:1995-03-13
Applicant: HOECHST AG
Inventor: WEIDMANN KLAUS DR , BICKEL MARTIN DR , GUNZLER-PUKALL VOLKMAR
IPC: C07D213/81 , A61K31/44 , A61K31/4418 , A61P1/16 , A61P3/00 , A61P11/00 , A61P43/00 , C07D213/82 , C07D213/89
Abstract: Sulphonamidocarbonyl pyridine-2-carboxylic acid ester amide derivs. of formula (I) and their pyridine N-oxides are new. R1 = OH or 1-6C alkoxy; R2, R3 = H, opt. substd. 1-6C alkyl, 1-6C alkoxy, halogen (esp. F, Cl or Br), CN, OH or NH2; R6 = H, 1-6C alkyl or a N-protecting gp., a 1-4 valent cation or a cation of a basic amino acid; R7 = Y-(Y'U)rDW but not SO3H; Y = SO2 or CO; Y' = bond or 1-16C alkanediyl, 3-10C cyclic alkanediyl, 2-16C alkenediyl, 2-16C cycloalkenediyl, 2-16C alkynediyl, 2-16C alkenynediyl, opt. contg. more than 1 C-C multiple bond; U = bond, H (sic), CO, OCO, COO, CONR, NRCO, O, SO, SO2, NR; R = 1-3C alkyl or H; r = 1-4; D = bond, H (sic), 1-10C alkanediyl, 1-10C alkenediyl, 2-10C alkynediyl, 2-10C alkenynediyl, opt. contg. more than one C-C multiple bond; W = bond (sic), H, 3-10C cycloaliphatic alkyl, 3-10C alkenyl, 3-10C alkynyl or 3-10C alkenynyl, 6-16C aryl or 5-6 membered heteroaryl; R4 = H, 1-6C alkyl, Ph or phenyl(1-4C)alkyl; R5 = aliphatic 1-8C alkyl, (mono-substd. by 1-12C alkoxycarbonyl, 1-12C alkoxy(1-2C)alkoxycarbonyl, 3-8C cycloalkoxycarbonyl, 3-12C alkenyloxycarbonhyl, or 3-12C alkynyloxycarbonyl), and which is opt. substd. with one or more substitutents (sic); with provisos.
-
公开(公告)号:SG45503A1
公开(公告)日:1998-01-16
申请号:SG1996010735
申请日:1996-09-27
Applicant: HOECHST AG
Inventor: WEIDMANN KLAUS DR , BARINGHAUS KARL-HEINZ DR , TSCHANK GEORG DR , BICKEL MARTIN DR
IPC: A61K31/47 , A61P1/16 , A61P11/00 , A61P17/00 , A61P37/00 , A61P43/00 , C07D215/16 , C07D215/48 , C07D215/60 , C07K5/078 , C07D
Abstract: 3-Hydroxyquinoline-2-carboxamide derivs. (I) and their salts are new. A =1-4C alkylene (opt. mono- or disubstd. by V, 1-6C hydroxyalkyl, Ph, benzyl, OPh, benzyloxy, anilino, N-methylanilino, SPh, SOPh or SO2Ph; or opt. monosubstd. by 6-12C aryl, 6-12C aryloxy, 7-11C aralkyl or 7-11C aralkoxy (all opt. mono- to penta- substd. by V, OCF2Cl or O-CF2-CHFCl); or 1 or more Rx); V = halo, CN, NO2, CF3, 1-6C alkyl, 1-6C alkoxy, -O-(CH2)x-CfH(2f+1-g)Halg, 1-6C alkylthio, 1-6C alkylsulphinyl, 1-6C alkylsulphonyl, 1-6C alkylcarbonyl, 1-6C alkoxycarbonyl, CONH2 (opt. mono- or disubstd. by 1-4C alkyl), 1-6C alkylcarbonyloxy, 3-8C cycloalkyl or SO2NH2 (opt. mono- or disubstd. by 1-4C alkyl); B = COOH, CONHCOR''', CONHSOR''', CONHSO2R''', NHSO2CF3, tetrazolyl, imidazolyl or 3-hydroxyisoxazolyl; R''' = aryl, heteroaryl, 3-7C cycloalkyl or 1-4C alkyl, opt. monosubstd. by 6-12C aryl, heteroaryl, OH, SH, 1-4C alkyl, 1-4C alkoxy, 1-4C alkylthio, alkylsulphinyl or alkylsulphonyl, CF3, Cl, Br, F, I, NO2, COOH, 2-5C alkoxycarbonyl, mono- or di- (1-4C alkyl)amino or 1-4C perfluoroalkyl; R1-R5 =H, OH, halo, CN, CF3, NO2, COOH, V', OV', 1-12C alkyl or alkoxy (both substd. by 3-8C cycloalkyl, 3-8C cycloalkoxy or 1-20C alkoxy), 3-8C cycloalkyl-1-8C alkyl-1-6C alkoxy, 7-16C aralkenyl; 7-16C aralkynyl, retinyloxy, 1-12C alkoxy-1-12C alkyl, 1-12C alkoxy-1-8C alkoxy-1-8C alkyl, OV', 1-6C alkoxy (substd. by 6-12C aryloxy or 7-16C aralkoxy), 1-16C hydroxyalkyl, 1-8C alkyl (substd. by 6-16C aryloxy or 7-16C aralkoxy), 1-6C alkyl (substd. by OCyc-substd. 1-8C alkoxy, 1-12C alkyl-thio, -sulphinyl, -sulphonyl, 6-12C arylthio, etc., -O-(CH2)x-CfH(2f+1-g)Halg, 1-6C chlorofluoroalkoxy, COV', COCyc, cinnamoyl, COOV', COOCyc, OCOV", OCOCyc, cinnamoyloxy, OCOOV', OCOOCyc, CONH2 (opt. mono- or disubstd., by 1-12C alkyl or by 3-8C cycloalkyl), CONE, COÄNRq-CHRx-COÜs-T, carbamoyloxy (opt. mono- or disubstd. by 1-12C alkyl), OCONHCyc, NRyRz, 1-8C alkyl (substd. by 1-12C alkanoylamino, etc.), 1-20C alkyl-thio, -sulphinyl, -sulphonyl, 6-12C arylthio, etc.; or 2 adjacent gps. of R1-R5 form 3-5C n-alkylene or n-alkenylene (opt. with 1 or 2 CH2 replaced by O, S, SO, SO2 or NR'); V' = 1-20 C alkyl, 2-20C alkenyl or 2-20C alkynyl; V" = 1-12C alkyl, 2-12C alkenyl or 2-12C alkynyl; Cyc = 3-8C cycloalkyl, 6-12C aryl or 7-16C aralkyl; E = 3-7C n-alkylene (opt. with one CH2 replaced by O, S, 1-8C alkylimino, N(Cyc), 3-8C cycloalkyl-1-12C alkylimino or 1-12C alkoxy-1-6C alkylimino); Rx = L- or D- alpha -amino acid substit.; T = OH, OR, or NRqRq; Rq = independently H, 6-12C aryl, 7-11C aralkyl, 1-8C alkyl, 3-8C cycloalkyl, (+)-dehydroabietyl, 1-8C alkyl (substd. by 1-8C alkoxy, 7-12C aralkoxy or 6-12C aryloxy), 1-10C alkanoyl, opt. substd. 7-16C aralkanoyl or opt. substd. 6-12C aroyl; or Rq+Rq = 3-7C n-alkylene (opt. with one CH2 replaced by O, S, SO, SO2, N-acylimino, etc.); R' = H, 6-12C aryl, 1-8C alkyl (opt. substd. by 1-8C alkoxy, 7-12C aralkoxy or 6-12C aryloxy), 1-10C alkanoyl, opt. substd. 7-16C aralkanoyl or opt. substd. 6-12C aroyl; Ry, Rz = V", 1-12C alkoxy, 3-8C cycloalkyl, 6-12C aryl, 7-11C aralkyl, 7-12C aralkoxy, 1-12C alkanoyl, 3-8C cycloalkanoyl, 6-12C aroyl or 7-16C aralkanoyl; or Ry+Rz = 3-6C n-alkylene, opt. with 1 CH2 replaced by O, S, N-(1-4C alkyl)carbonylimino or N-(1-4C alkoxy)carbonylimino; f = 1-8; g = 0 - (2f+1); m = 0 or 1; s = 1-5; x = 0-3; aryl gps. are all opt. substd., (where two of the substits. may be fused to form a CH2 chain (opt. with a CH2 replaced by O, S, SO, SO2 or NR') or CH=CH-CH=CH).
-
公开(公告)号:ES2104758T3
公开(公告)日:1997-10-16
申请号:ES92104584
申请日:1992-03-17
Applicant: HOECHST AG
Inventor: BAADER EKKEHARD DR , BICKEL MARTIN DR , GUNZLER-PUKALL VOLKMAR DR , VOLZ MANFRED DR
IPC: A61K31/44 , A61K31/4402 , A61K31/455 , A61K31/5377 , A61P1/16 , A61P9/10 , A61P11/00 , A61P19/04 , A61P37/06 , A61P43/00 , C07D213/81 , C07D213/82
Abstract: The invention relates to mixed pyridine-2,4- and -2,5-dicarboxylic acid diamides, the carboxylic acid amide group in position 2 being a primary acid amide. The said compounds are suitable for the inhibition of proline hydroxylase and lysine hydroxylase and are used as fibrosuppressants and immunosuppressants.
-
公开(公告)号:DK0661269T3
公开(公告)日:1997-10-13
申请号:DK94120766
申请日:1994-12-27
Applicant: HOECHST AG
Inventor: WEIDMANN KLAUS DR , BARINGHAUS KARL-HEINZ DR , TSCHANK GEORG DR , BICKEL MARTIN DR
IPC: C07D237/24 , A61K31/44 , A61K31/4418 , A61K31/4427 , A61K31/47 , A61K31/50 , A61K31/535 , A61P1/16 , A61P9/10 , A61P11/00 , A61P17/00 , A61P43/00 , C07D213/79 , C07D213/81 , C07D213/82 , C07D213/83 , C07D213/89 , C07D215/48 , C07D247/00 , C07D401/12 , C07D403/12 , C07D413/12 , C07D471/04 , C07D487/04 , C07D495/04 , C07K5/078
Abstract: The invention relates to the compound of the formula I, a process for its preparation and its use as a medicament. In particular, the compounds are employed as inhibitors of prolyl-4-hydroxylase and as inhibitors of collagen biosynthesis in medicaments for fibrotic diseases of the liver, the lungs and the skin.
-
-
-
-
-
-
-
-
-